ALKemy to enhance chimeric antigen receptor T cell immunotherapy for neuroblastoma
Cancer Cell · 2023
DOI: 10.1016/j.ccell.2023.11.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2023. Verfasst von Marco Ruella. Beteiligte Einrichtung: Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Medicine, Di…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neuroblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: NCI NIH HHS, Beckman Coulter Foundation, Office of National Intelligence.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T cell immunotherapy in solid cancer is severely limited by the absence of ideal targets. In this issue of Cancer Cell, Bergaggio et al. find that anaplastic lymphoma kinase (ALK) inhibitors can enhance the function of ALK-specific CAR T cells against neuroblastoma by increasing target density in cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine at the…
Förderung
- NCI NIH HHS
- Beckman Coulter Foundation
- Office of National Intelligence
- Leukemia and Lymphoma Society
- Hairy Cell Leukemia Foundation
- Gabrielle's Angel Foundation for Cancer Research
- Laffey-McHugh Foundation
- National Institutes of Health
Zitieren
APA
Ruella, M. (2023). ALKemy to enhance chimeric antigen receptor T cell immunotherapy for neuroblastoma. Cancer Cell. https://doi.org/10.1016/j.ccell.2023.11.009
Vancouver
Ruella M. ALKemy to enhance chimeric antigen receptor T cell immunotherapy for neuroblastoma. Cancer Cell. 2023. doi:10.1016/j.ccell.2023.11.009
BibTeX
@article{Ruella2023,
author = {Ruella, Marco},
title = {ALKemy to enhance chimeric antigen receptor T cell immunotherapy for neuroblastoma},
journal = {Cancer Cell},
year = {2023},
doi = {10.1016/j.ccell.2023.11.009}
}
EUVIMED